A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Organon and Co611 enrolled

Overview

The purpose of this study is to assess the cholesterol lowering effects of an investigational drug in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

611

Conditions

Hyperlipidemia Hypercholesterolemia Hypertriglyceridemia

Interventions

ezetimibe (+) simvastatinDRUG

Duration of Treatment: 6 months

Eligibility

Sex: ALLMin age: 18 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men and women 18-79 years of age with high cholesterol and high triglycerides. Exclusion Criteria: * Individuals who do not meet specific cholesterol or triglyceride levels as required by the study.

Outcomes

Primary Outcomes

Plasma LDL-C.

Secondary Outcomes

Plasma HDL-C, non-HDL-C, and TG. Tolerability

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.